首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   679篇
  免费   39篇
  国内免费   14篇
耳鼻咽喉   2篇
儿科学   9篇
妇产科学   8篇
基础医学   118篇
口腔科学   7篇
临床医学   45篇
内科学   131篇
皮肤病学   11篇
神经病学   22篇
特种医学   9篇
外科学   78篇
综合类   67篇
预防医学   92篇
眼科学   8篇
药学   43篇
中国医学   1篇
肿瘤学   81篇
  2023年   15篇
  2022年   20篇
  2021年   27篇
  2020年   9篇
  2019年   22篇
  2018年   59篇
  2017年   19篇
  2016年   23篇
  2015年   12篇
  2014年   25篇
  2013年   18篇
  2012年   25篇
  2011年   45篇
  2010年   31篇
  2009年   43篇
  2008年   35篇
  2007年   50篇
  2006年   34篇
  2005年   35篇
  2004年   19篇
  2003年   20篇
  2002年   11篇
  2001年   9篇
  2000年   2篇
  1999年   10篇
  1998年   6篇
  1997年   8篇
  1996年   6篇
  1995年   3篇
  1994年   6篇
  1993年   6篇
  1992年   3篇
  1991年   3篇
  1990年   1篇
  1989年   1篇
  1988年   2篇
  1986年   2篇
  1985年   7篇
  1984年   15篇
  1983年   7篇
  1982年   8篇
  1981年   7篇
  1980年   3篇
  1979年   5篇
  1978年   4篇
  1977年   5篇
  1976年   1篇
  1975年   3篇
  1974年   2篇
排序方式: 共有732条查询结果,搜索用时 15 毫秒
51.
宫颈癌组织HPV58的检测及其E7基因的克隆和表达   总被引:2,自引:0,他引:2  
目的 检测宫颈癌组织中人乳头瘤病毒 5 8型 (HPV5 8)并克隆表达其E7基因。方法采用GP5 /GP6 引物系统扩增 5 8例宫颈癌组织 ,将荧光偏振 (FP)检测技术与模板指导的末端延伸反应 (TDI FP)结合 ,检测HPV5 8,确定HPV5 8感染阳性宫颈癌组织。用特异引物从HPV5 8阳性标本中扩增HPV5 8早期表达蛋白E7基因 ,将其连入pGEM TEasy载体 ,获得克隆重组体HPV5 8E7 pGEM T ,并测序验证。将E7基因与pRSET A融合表达载体连接 ,获得E7表达重组体pRSET 5 8E7,转化大肠杆菌BL2 1(DE3) ,并用IPTG诱导表达。结果  5 8例宫颈癌标本中 ,HPV5 8阳性 10例 ,占 5 2例HPV阳性标本的 19.2 %。从其中扩增到了HPV5 8E7基因并构建了其克隆和表达重组体。其表达重组体经IPTG诱导后 ,可表达Mr16× 10 3 的HPV5 8E7His6融合蛋白 ,表达量占菌体蛋白的 30 %。结论 欧美国家少见的高危HPV5 8在中国陕西人宫颈癌组织中并不少见。HPV5 8E7重组表达体可在大肠杆菌中高效表达 ,为HPV5 8相关肿瘤诊断试剂及疫苗的研制奠定了初步基础  相似文献   
52.
PURPOSE: To assess the potential clinical value of alpha-tocopherol-loaded poly (DL-lactic-co-glycolic acid) (PLGA) microspheres, we examined the disposition kinetics of alpha-tocopherol after administration of the microspheres to apolipoprotein B (apo B) knockout mice as a model of abetalipoproteinemia. METHODS: PLGA microspheres containing alpha-tocopherol were prepared by a solvent-evaporation method. The concentration of alpha-tocopherol was measured by gas chromatography-mass spectrometry. RESULTS: The mean value of particle size of alpha-tocopherol-loaded PLGA microspheres was 108 microm. The loading and the trapping efficiency of alpha-tocopherol in PLGA microspheres were 20.8% and 86.6%, respectively. When alpha-tocopherol solution (25 mg/kg) was subcutaneously administered to apob (+/+) and apob (+/-) mice, the plasma concentrations of alpha-tocopherol reached a peak at 6 h and decreased to the endogenous level within 4 days in both types of mice. However, the area under the plasma concentration-time curve (AUC) of apob (+/-) mice was significantly smaller than that in the case of apob (+/+) mice. When alpha-tocopherol-loaded PLGA microspheres (100 mg/kg) were subcutaneously administered, the plasma concentrations of alpha-tocopherol increased slowly and remained about 2-fold higher than the endogenous level at 5 to 10 days after administration in both types of mice, and there was no significant difference between the AUC values. CONCLUSIONS: The PLGA microsphere preparation of alpha-tocopherol is expected to be a very useful drug delivery system in vitamin E supplementation therapy for abetalipoproteinemia.  相似文献   
53.
Summary The 2 day post partum mouse Crista ampullaris was cultured in vitro for 7 days. The differentiation into secretory and sensory areas was preserved. The ultrastructure of the dark cells of the secretory region was well maintained. The hair cell morphologically was considerably changed though the hair cells themselves survived 7 days in culture.Supported by grants from Karolinska Institutet, and Swedish Medical Research Council (Grant No. 12X-720)  相似文献   
54.

BACKGROUND:

Lung cancer is the leading cause of cancer‐related deaths worldwide. Epigenetic inactivation of certain genes by aberrant promoter methylation is recognized as a crucial component in the initiation and progression of lung cancer. Response gene to complement 32 (RGC32) has been identified as a cell cycle regulator induced by activation of complements; however, its role in carcinogenesis is still controversial.

METHODS:

The authors examined the methylation status in the promoter region of RGC32 gene in nonsmall cell lung cancers (NSCLCs) using a methylation‐specific PCR and correlated the results with clinicopathological features.

RESULTS:

RGC32 methylation was found in 45 of 173 NSCLCs (26.0%) and was related to the gene expression. RGC32 methylation was more frequent in females than in males (P<0.05). RGC32 methylation was not significantly associated with the prognosis of patients; however, when the patients were categorized by TP53 mutational status, the effect of RGC32 methylation on prognosis was significantly different between those with and without TP53 mutations (P = .005 [test for homogeneity]). Specifically, RGC32 methylation was associated with significantly worse survival in the cases with wild‐type TP53, whereas it exhibited a better survival outcome in the cases with TP53 mutations.

CONCLUSIONS:

The current findings suggest that methylation‐associated down‐regulation of RGC32 plays an important role in the pathogenesis of NSCLC, particularly in females. However, further studies with a large number of cases are needed to confirm the authors' findings. Cancer 2011. © 2010 American Cancer Society.  相似文献   
55.
56.
57.

Objective

The objective of this study was to evaluate the early and long-term outcome of cryopreserved arterial allografts (CAAs) used for in situ reconstruction of abdominal aortic native or secondary graft infection and to identify predictors of mortality.

Methods

We retrospectively included 71 patients (mean age, 65.2 years [range, 41-84 years]; men, 91.5%) treated for abdominal aortic native or secondary graft infection (65 prosthetic graft infections; 16 of them had secondary aortoenteric fistula, 2 venous graft infections, and 4 mycotic aneurysms) by in situ reconstruction with CAA in the university hospitals of Clermont-Ferrand and Saint-Etienne from 2000 to 2016. The cryopreservation protocol was identical in both centers (?140°C). Early (<30 days) and late (>30 days) mortality and morbidity, reinfection, and CAA patency were assessed. Computed tomography was performed in all survivors. Survival was analyzed with the Kaplan-Meier method. Univariate analyses were performed with the log-rank test and multivariate analysis with the Cox regression model.

Results

Mean follow-up was 45 months (0-196 months). Early postoperative mortality rate was 16.9% (11/71). Early postoperative CAA-related mortality rate was 2.8% (2/71); both patients died of proximal anastomotic rupture on postoperative days 4 and 15. Early CAA-related reintervention rate was 5.6% (4/71); all had an anastomotic rupture, and two were lethal. Early postoperative reintervention rate was 15.5% (11/71). Intraoperative bacteriologic samples were positive in 56.3%, and 31% had a sole microorganism. Escherichia coli was more frequently identified in the secondary aortoenteric fistula and Staphylococcus epidermidis in the infected prosthesis. Late CAA-related mortality rate was 2.8%: septic shock at 2 months in one patient and proximal anastomosis rupture at 1 year in one patient. Survival at 1 year, 3 years, and 5 years was 75%, 64%, and 54%, respectively. Multivariate analysis identified type 1 diabetes (hazard ratio, 2.49; 95% confidence interval, 1.05-5.88; P = .04) and American Society of Anesthesiologists class 4 (hazard ratio, 2.65; 95% confidence interval, 1.07-6.53; P = .035) as predictors of mortality after in situ CAA reconstruction. Reinfection rate was 4% (3/71). Late CAA-related reintervention rate was 12.7% (9/71): proximal anastomotic rupture in one, CAA branch stenosis/thrombosis in five, ureteral-CAA branch fistula in one, and distal anastomosis false aneurysm in two. Primary patency at 1 year, 3 years, and 5 years was 100%, 93%, and 93%, respectively. Assisted primary patency at 1 year, 3 years, and 5 years was 100%, 96%, and 96%, respectively. No aneurysm or dilation was observed.

Conclusions

The prognosis of native or secondary aortic graft infections is poor. Aortic in situ reconstruction with CAA offers acceptable early and late results. Patients with type 1 diabetes and American Society of Anesthesiologists class 4 are at higher risk of mortality.  相似文献   
58.

Background

Supra-acetabular insufficiency fractures (SAIFs) occur in the upper acetabulum and are rare compared with insufficiency sacral, femoral head, or ischial fractures. However, SAIFs are known to occur in low grade trauma, and the underlying mechanism is still remained unclear.

Methods

We performed biomechanical analysis using finite element analysis to clarify the mechanisms underlying the development of SAIFs. Patient-specific models and bone mineral density (BMD) were derived from pelvic computed tomography data from two patients with SAIF (unaffected side) and two healthy young adults. The bone was assumed to be an isotropic, linearly elastic body. We assigned Young's modulus of each element to the pelvis based on the BMD, and reported the relationships for BMD–modulus. Clinically relevant loading conditions—walking and climbing stairs—were applied to the models. We compared the region of failure risk in each acetabulum using a maximum principal strain criterion.

Results

The average supra-acetabular BMD was less than that of the hemi-pelvis and femoral head, but was higher than that of the femoral neck and greater trochanter. Greater minimum principal strain was concentrated in the supra-acetabular portion in both the SAIF and healthy models. In the SAIF models, the higher region of the failure risk matched the fracture site on the acetabulum.

Conclusions

Relative fragility causes compressive strain to concentrate in the upper acetabulum when walking and climbing stairs. When presented with a patient complaining of hip pain without apparent trauma or abnormal X-ray findings, physicians should consider the possibility of SAIF and perform magnetic resonance imaging for the diagnosis of SAIF.  相似文献   
59.
60.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号